Phase I study of once weekly treatment with bortezomib in combination with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma.

Cite this paper

@article{Totani2016PhaseIS, title={Phase I study of once weekly treatment with bortezomib in combination with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma.}, author={Haruhito Totani and Masaki Ri and Chie Kato and Takahiro Nakashima and Nana Suzuki and Shinya Hagiwara and Takashi Kanamori and Satsuki Murakami and Arisa Masuda and Shiori Kinoshita and Takashi Yoshida and Tomoko Narita and Asahi Ito and Shigeru Kusumoto and Takashi Ishida and Hirokazu Komatsu and Shinsuke Iida}, journal={International journal of hematology}, year={2016}, volume={103 3}, pages={316-21} }